Celcuity, Inc. (CELC)

107.82 +3.61 (+3.46%) USD  |  NASDAQ  |  Jan 14, 10:14
More

Celcuity Other Long Term Liabilities (Quarterly)

Other Long Term Liabilities (Quarterly) Chart

View Other Long Term Liabilities (Quarterly) for CELC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Other Long Term Liabilities (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Other Long Term Liabilities (Quarterly) Range, Past 5 Years

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Other Long Term Liabilities (Quarterly) Benchmarks

View Other Long Term Liabilities (Quarterly) Benchmarks
Start Trial
Olema Pharmaceuticals, Inc. --
Replimune Group, Inc. Upgrade
Arrowhead Pharmaceuticals, Inc. --
Cidara Therapeutics, Inc. --
Cogent Biosciences, Inc. Upgrade